Basics Immunocore Holdings IPO Date: February 5, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.61B Activated in VL: True Average Daily Range Avg Daily Range: $1.07 | 2.55% Avg Daily Range (30 D): $0.80 | 2.65% Avg Daily Range (90 D): $0.73 | 2.47% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 74 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 1,588 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $1.3M Avg Inst. Trade (90 D): $1.82M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $.89M Avg Closing Trade (90 D): $1.02M Avg Closing Volume: 33.68K         News Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A Mar 6, 2025 @ 6:00 PM TCR Therapy Clinical Trial Pipeline Accelerates as... Source: Delveinsight Jan 6, 2025 @ 12:00 PM Immunocore to present at the 43rd Annual J.P. Morg... Source: N/A Jan 2, 2025 @ 12:00 PM Immunocore appoints Travis Coy, previously a Non-E... Source: N/A Dec 23, 2024 @ 12:00 PM Immunocore announces first patient dosed in the Ph... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.43 $.1 $-.47 Diluted EPS $-.43 $.1 $-.47 Revenue $ 333.58M $ 93.88M $ 84.05M Gross Profit $ 330.27M $ 93.05M $ 83.72M Net Income / Loss $ -21.63M $ 5.02M $ -23.77M Operating Income / Loss $ -47.59M $ -3.62M $ -19.45M Cost of Revenue $ 3.32M $ .83M $ .33M Net Cash Flow $ -355.98M $ 21.11M $ -82.04M PE Ratio